Abstract: The present invention is a semiconductor nanoparticle composed of a semiconductor crystal of a compound containing Ag, Au and S as essential constitutional elements. A AgAuS-based compound constituting the semiconductor nanoparticle has a total content of Ag, Au and S of 95 mass % or more. In addition, the compound is preferably a AgAuS ternary compound represented by the general formula Ag(nx)Au(ny)S(nz). In the formula, n is any positive integer. x, y and z represent proportions of the number of atoms of the respective atoms of Ag, Au and S in the compound and are real numbers satisfying 0<x, y, z?1, and x/y is 1/7 or more and 7 or less.

Abstract: The present invention aims to provide a composition for promoting immune cell metabolism, a composition for activating immunity, a method of promoting immune cell metabolism, and a method of activating immunity. The present invention relates to a composition for promoting immune cell metabolism, which contains L-ergothioneine or a salt thereof as an active ingredient.

Abstract: The present invention relates to a medicament for treating or preventing central nervous system disease whose cause is related to abnormal aggregation of proteins in the brain, which comprises as an active ingredient a compound of formula (1) or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are hydrogen, etc., R3 and R4 are hydrogen, C1-6 alkyl, etc., R5 is halogen, C1-6 alkyl, etc., R6 is hydrogen, halogen, etc., X is oxygen, etc., Y is carbon, etc., m and n are an integer of 0, 1, etc., r and s are 0, 1, 2, etc., Hy is pyridine ring, etc., which has an action of suppressing or reducing the accumulation of abnormal aggregation of proteins in the brain.

Abstract: The medicine intake support device includes a processing circuitry and a memory. The processing circuitry acquires a previous medicine intake time and a next scheduled medicine intake time, wherein the previous medicine intake time is a time when a patient previously took a prescription medicine, and the next scheduled medicine intake time is a predetermined time when the patient will take a next dose of the prescription medicine. The memory stores a type of the prescription medicine and a measure in response to the patient's failure to take the type of the prescription medicine in correspondence with each other. If the patient failed to take the prescription medicine, the processing circuitry suggests a response method in response to the patient's failure to take the prescription medicine based on the measure stored in the memory, the previous medicine intake time, the next scheduled medicine intake time, and a current time.

Abstract: An image forming apparatus for compressing image data, includes: a compression unit that reduces data into a predetermined bit number per band of image data so as to satisfy a condition related to a predetermined compression and compresses the reduced data; a specifying unit that specifies a minimum bit number among the predetermined bit numbers applied to the bands and specifies bands which are not compressed by the minimum bit number; and a re-compression unit that performs re-compression on the specified bands so that the data is compressed by the minimum bit number.

Abstract: An image processing device configured to compress image data to be used for printing with a plurality of compression levels having different compression rates includes a former stage compression unit, a storing unit and a latter stage compression unit. The latter stage compression unit is configured, after the former stage compression unit finishes compressing all of the areas, to recompress each of areas of a latest compression level at the moment being different from a compression level stored in the storing unit with the latest compression level.

Abstract: An adhesive composition for forming an adhesive layer for temporarily fixing a substrate, such as a wafer, to a support when processing the substrate, the adhesive composition including a resin (A) produced by polymerizing a monomer component containing a cycloolefin-based monomer, at least one terpene-based resin, rosin-based resin, or petroleum resin (resin B), and an organic solvent capable of dissolving the resins (A) and (B). The resin (A) has a glass transition point of 60° C. or higher, the resin (B) has a softening point of 80 to 160° C. and a molecular weight of 300 to 3000, and the blending ratio of the resin (A) to the resin (B) is (A):(B)=80:20 to 55:45 (mass ratio).

Abstract: An image forming apparatus for compressing image data, includes: a compression unit that reduces data into a predetermined bit number per band of image data so as to satisfy a condition related to a predetermined compression and compresses the reduced data; a specifying unit that specifies a minimum bit number among the predetermined bit numbers applied to the bands and specifies bands which are not compressed by the minimum bit number; and a re-compression unit that performs re-compression on the specified bands so that the data is compressed by the minimum bit number.

Abstract: An image processing device configured to compress image data to be used for printing with a plurality of compression levels having different compression rates includes a former stage compression unit, a storing unit and a latter stage compression unit. The latter stage compression unit is configured, after the former stage compression unit finishes compressing all of the areas, to recompress each of areas of a latest compression level at the moment being different from a compression level stored in the storing unit with the latest compression level.